Sotera Health Company EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 37.57%

Sotera Health Company EBITDA Margin is 37.57% for the Trailing 12 Months (TTM) ending March 31, 2025, a -5.07% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Sotera Health Company EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 39.58%, a -1,206.56% change year over year.
  • Sotera Health Company EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -3.58%, a -108.15% change year over year.
  • Sotera Health Company EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 43.88%, a 17.44% change year over year.
  • Sotera Health Company EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 37.36%, a -1.05% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin